Vanda Pharmaceuticals Inc. (VNDA) delivered a return of 28.04% over the past year. Since VNDA does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Vanda Pharmaceuticals Inc. one year ago would be worth $12,804 today, representing a gain of $2,804.

Vanda Pharmaceuticals Inc. (VNDA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For VNDA, the total return equals the price-only return.

Yes, Vanda Pharmaceuticals Inc. (VNDA) outperformed the S&P 500 by 3.05 percentage points over the past year. VNDA delivered a total return of 28.04%, compared to the S&P 500's 24.99%. This 3.05pp alpha means investors in VNDA earned more than a passive S&P 500 index fund.

Vanda Pharmaceuticals Inc. (VNDA) experienced a maximum drawdown of -40.06% over the past year, declining from its peak on 2026-03-10 to its trough on 2026-06-16. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Vanda Pharmaceuticals Inc. (VNDA)'s long-term returns with dividends reinvested. Over 10 years, the total return is -47.8% (-6.3% CAGR) — $10,000 would have grown to $5,221. Over 20 years: -35.3% total return (-2.2% CAGR) — $10,000 → $6,466. Over 30 years: -40.1% total return (-1.7% CAGR) — $10,000 → $5,992. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Vanda Pharmaceuticals Inc.'s best calendar year was 2009 with a total return of 1945.5%. Its worst year was 2008 with a total return of -92.3%. This range shows the volatility investors should expect — the difference between the best and worst year is 2037.8 percentage points.